Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis.

To accommodate for this imbalance, we conducted a Cox regression analysis which revealed a higher overall survival rate for patients treated with WB-RT, although this did not reach statistical significance, most likely due to the small size of the cohort (WB-RT HR 0.43, 95% CI 0.17–1.08, p = 0.073) and a sustained non-significant benefit for thoracic TR (HR 0.39, 95% CI 0.14–1.052, p = 0.063).

also in 111,027 other papers